The contribution of melanocytes to pathological scar formation during wound healing

International Journal of Clinical and Experimental Medicine

Volumn 6, Issue 7, 2013, Pages 609-613

  Gao, Fu Lei ^a   Jin, Rong ^a   Zhang, Lu ^a   Zhang, Yu Guang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Fibroblast; Keloid; Melanocyte; Scar; Wound healing

Indexed keywords

ALPHA INTERFERON; ALPHA INTERMEDIN; COLLAGEN FIBER; COLLAGEN TYPE 1; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BASEMENT MEMBRANE; CELL GROWTH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COLLAGEN SYNTHESIS; EXTRACELLULAR MATRIX; HUMAN; HYPERTROPHIC SCAR; KELOID; MELANOCYTE; MELANOSOME; RACE DIFFERENCE; SCAR FORMATION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; WOUND HEALING;

EID: 84881071249     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Ketchum LD, Cohen IK, Maters FW. Hypertrophic scars and keloids: A collective review. Plast Reconstr Surg 1974; 53: 140-154.
2. Zhang LX, Guo SZ, Wang Z. Biological effects of supernatant from melanocytes culture on proliferation of hypertrophic scar fibroblasts. J Fourth Mil Med Univ 2000; 21: 669-670.
3. Zhang Z, Garron TM, Li XJ, Liu Y, Zhang X, Li YY and Xu WS. Recombinant human decorin inhibits TGF-beta1-induced contraction of collagen lattice by hypertrophic scar fibroblasts. Burns 2009; 35: 527-537.
4. Chen J, Qian YL, Yang J and Wang DR. Pingyangmycin in treatment of keloids: a clinical and experimental study. Chinese Journal of Medical Aesthetics and Cosmetology 2009; 15: 110-113.
5. Gao FL, Zhang YG, Wang DR. Advance in blocking TGF-β signaling pathway in different levels. Chinese Journal of Injury Repair and Wound Healing 2007; 2: 181-183.
6. Zhu Q, Li J. A combined candidate therapy for the scar-free repair of cleft lip based on inhibitors of TGF-β. Med Hypotheses 2011; 76: 86-88.
7. Zhang ZF, Zhang YG, Hu DH, Shi JH, Liu JQ, Zhao ZT, Wang HT, Bai XZ, Cai WX, Zhu HY and Tang CW. Smad interacting protein 1 as a regu lator of skin fibrosis in pathological scars. Burns 2011; 37: 665-672.
8. Wang R, Ghahary A, Shen Q, Scott PG, Roy K and Tredget EE. Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells. Wound Repair Regen 2000; 8: 128-137.
9. Chin GS, Liu W, Peled Z, Lee TY, Steinbrech DS, Hsu M and Longaker MT. Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts. Plast Reconstr Surg 2001; 108: 423-429.
10. Lin X, Duan X, Liang YY, Su Y, Wrighton KH, Long J, Hu M, Davis CM, Wang J, Brunicardi FC, Shi Y, Chen YG, Meng A and Feng XH. PPM1A functions as a Smad Phosphatase to Terminate TGF-beta Signaling. Cell 2006; 125: 915-928.
11. Cario-André M, Pain C, Gauthier Y, Casoli V and Taieb A. In vivo and in vitro evidence of dermal fibroblasts influence on human epidermal pigmentation. Pigment Cell Res 2006; 19: 434-442.
12. Taylor AW, Yee DG, Nishida T, Namba K. Neuropeptide regulation of immunity. The immunosuppressive activity of alpha-melanocyte-stimulating hormone(alpha-MSH). Ann N Y Acad Sci 2000; 917: 239-247.
13. Zheng JS, Xing X, Zheng QY and Xue CY. Expression of α-melanocyte-stimulating hormone in keloid-derived fibroblasts and its effects on keloid-derived fibroblasts. Chinese Journal of Practical Aesthetic and Plastic Surgery 2005; 16: 68-70.